News

23 September 2026 | 15:00–16:00 CEST

How can prisons eliminate viral hepatitis?

Join the webinar introducing the European Toolkit for the Elimination of Viral Hepatitis in Prisons (EuroHePP), developed and published by the European Centre for Disease Prevention and Control (ECDC) and the European Union Drugs Agency (EUDA).

The webinar, delivered by EACS and CHIP, will explore how the toolkit can be applied in practice. Participants will hear from experts in Milan (Italy) and Montpellier (France) who will share experiences on how they scaled up hepatitis B and C prevention and care in their prison settings. The aim is for participants to leave the webinar having learned how the toolkit can be applied in practice and having identified transferable actions and next steps for their local context.

Participation is free of charge, but registration is required.

Register for the webinar via Zoom

Further information, including the agenda and background materials, is available through the ECDC Learning Portal

Find out more about the EuroHePP Toolkit

The EACS HIV Summer School 2026 brought together 60 early-career HIV clinicians and clinical scientists from 27 countries for five days of education, discussion and international exchange in Lyon, France, from 31 August to 4 September.

Participants took part in a high-level educational programme designed to strengthen both their clinical and research skills. The Summer School combines updates on current issues in HIV diagnosis, management and prevention with practical training in medical statistics and clinical research methodology.

A strength of the Summer School is the opportunity to learn directly from an outstanding international faculty. It brings together expertise spanning HIV clinical care, epidemiology, biostatistics, clinical research, HIV cure, ageing, co-morbidities, viral hepatitis, prevention and sexual and reproductive health.

Bringing together participants from across Europe, the event's mix of clinical case working groups, informal discussions and social activities helped create opportunities for early-career professionals to exchange experiences, establish international connections and engage directly with experienced colleagues.

Thank you to all participants, faculty and the Organising Committee for making HIV Summer School 2026 a success.

Learn more about the HIV Summer School

SARS, pandemic flu A(H1N1), MERS, Ebola, Zika, pulmonary plague, COVID-19, mpox. During the last 25 years, we have witnessed an acceleration in the emergence of infectious diseases and pandemics.

This course is designed for students willing to understand the origin of pandemics, factors associated with their spread, and innovative ways to control them.

The course, provided by Institut Pasteur, will take place from 18 to 29 January 2027 in Paris. Applications to participate are open until 31 October 2026.

Learn more about the course

Mark your calendars for the HepHIV2026 Conference, organised by EuroTEST, that will take place on 2 and 3 November 2026 in Dublin, Ireland.

The main theme of the conference is to progress toward the Sustainable Development Goals and other global targets related to testing and linkage to care for HIV, viral hepatitis, STIs and TB. The aim is to bring together stakeholders from all levels of the health system, from community organisations to healthcare providers and policy makers, to present and discuss new approaches for testing and linkage to care for HIV, viral hepatitis, sexually transmitted infections (STIs) and tuberculosis (TB), highlighting programmatic/implementation issues and adaptation of testing services in response to emerging public health issues.

Learn more about the conference programme, registration and other useful information

The WEEPI Foundation announced the launch of its 2026 Seed Grants Programme, supporting clinical and implementation research on HIV, viral hepatitis, and tuberculosis, in Eastern Europe and Central Asia.

WEEPI welcomes applications from universities, research institutes, and non-profit organisations, and encourages collaborations between partners across Eastern and Western Europe. The main applicant must be based in Eastern Europe. Priority will be given to projects that improve healthcare access, promote sustainability, and strengthen long-term research capacity. The grant covers 30,000 CHF for one year.

Learn more and apply by 30 September 2026

Our Review in The Lancet HIV examines the rapidly changing molecular landscape of HIV-1 across the WHO European Region, including the expansion of subtype A6, the growing contribution of non-B subtypes, and the increasing frequency of circulating and unique recombinant forms which are reshaping the epidemic.

These changes are not only epidemiological. Subtype-specific genetic backgrounds may influence virulence, resistance pathways, interpretation of genotypic testing, and the durability of long-acting cabotegravir–rilpivirine treatment. Viral diversity may also affect susceptibility to fostemsavir, broadly neutralising antibodies, pre-exposure prophylaxis, reservoir dynamics, and future cure strategies.

The paper also highlights how migration, conflict, and refugee movements are reshaping HIV molecular diversity in Europe, making genomic surveillance increasingly relevant for clinical care and public health.

The review highlights why molecular surveillance, subtype-aware clinical interpretation, and inclusive drug-development studies are essential for equitable HIV prevention and treatment across Europe.

Congratulations to my co-authors Karol Sherwin, Dimitri’s Paraskevis, Thomas Klimkait, Charlotte Charpentier, Annemarie Wensing for this important contribution.

Published in The Lancet HIV - Reference: LANHIV1995 (Free access until 30 July 2026)

The research article entitled ‘Models of care for women living with HIV in Europe: A scoping review’ is now published in HIV Medicine.

Overall, the findings emphasise the need for integrated, life-course approaches that go beyond virological outcomes and better address social and structural determinants, while expanding women-centred services, particularly in Eastern Europe.

Read the article

On 28 and 29 May 2026 (16:00- 17:45 CEST) the 14th WAVE in Ukraine online workshop will take place.

The series started with an onsite meeting in 2019 and has continued online since 2021. This time, the meeting will focus on Mental wellbeing and treatment adherence in women living with HIV and Metabolic disorders in women living with HIV.

The workshop will be available in English and Ukrainian.

Register and find more information here.